Tuesday, February 12, 2019
Melissa Boileau, MD
Transfusion Medicine Trainee
University of Toronto
1. Review current guidelines on utilization and inventory management of group O Rh(D)-negative red cells.
2. Identify where universal donor blood is being used.
3. Evaluate how utilization of O Rh(D)-negative red cells can be reduced by using various switching rules based on the recipient’s age and hospital location.
1. O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study. Dunbar NM, Yazer MH; OPTIMUS Study Investigators on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion. 2018 Jun;58(6):1348-1355. doi: 10.1111/trf.14547. Epub 2018 Feb 25. PMID: 29479703
Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.
To register for the LearnTransfusion series, send an email to firstname.lastname@example.org with “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail, and confirm that you would like to register for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g., call-in number and a link to register for the webinar).
The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.